Aspect Imaging Introduces Imaging Tools to Streamline Research

Aspect Imaging has unveiled its M-series of compact magnetic resonance (MR) imaging systems specialized for pre-clinical research, as well as a brand new integrated simultaneous PET-MRI that combines positron emission tomography (PET) and magnetic resonance imaging (MRI) modalities. In addition, Aspect Imaging is introducing a new Optical and MRI fusion system. The simple-to-use, efficient, and flexible MRI systems enable rapid in vivo drug efficacy studies.
 
The company is introducing a brand new MRI system that combines PET and MRI modalities for simultaneous PET-MRI research. This system is based on the M7 compact MRI, and is the world’s first permanent magnet commercial product for Simultaneous PET/MRI for Preclinical research, according to executives.
 
In addition, the company is presenting a novel optical and MRI fusion technique based on a proprietary animal transport system. This opens the door for the BLI optical research community to fuse optical data with MRI data and take advantage of the exceptional soft tissue image quality provided by the MRI, at an inexpensive cost. This new animal transport system is compatible with the M3 and the M7 compact MRI systems and is compatible with IVIS Spectrum CT, manufactured by PerkinElmer Inc. allowing precise co-localization between 3D optical and MRI data. The fused data is presented from a PerkinElmer Spectrum IVIS CT system.
 
Furthermore, the new Aspect Imaging automated MR-based histology solution enables rapid drug efficacy studies that save time and money.
 
Aspect Imaging’s unique compact MRI systems utilize one-touch MRI, an intuitive user-friendly interface that operates both the M3 and M7. This software has been developed and manufactured to provide a straightforward and reasonably simple-to-operate workstation, so that anyone can operate the MRI. Additionally, the system is built for flexibility and mobility, allowing the station be placed in practically any research facility.
 
“Our series of preclinical solutions offer researchers the only MRI system they will need to perform all of their animal studies,” said Uri Rapoport, founder, president and CEO of Aspect Imaging.
 
Aspect Imaging is part of Aspect Intl. LLC, a Singapore-based company that designs and develops compact MR imaging and NMR systems for medical, advanced industrial and preclinical applications. Founded in 2014, the company is headed by Rapoport, who has founded and led several Israeli and U.S. companies in the fields of NMR and MRI. He holds multiple worldwide and U.S. patents in the fields of nuclear magnetic resonance spectroscopy, MRI, and GPS.